Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trial

Citation:

Doi Y, Hamano T, Yamaguchi S, Sakaguchi Y, Kaimori JY, Isaka Y. Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trial. Diabetes Obes Metab. 2023 Jun 29. doi: 10.1111/dom.15191. Epub ahead of print. PMID: 37385955.